Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas

BACKGROUND: In patients with adenocarcinoma of the pancreas, there are no standard second-line regimens. Many pre-clinical studies have shown that metformin alone or when combined with paclitaxel has antitumour effects on this tumour. We have tested here the combination of paclitaxel and metformin f...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ecancermedicalscience
Main Authors: Braghiroli, Maria Ignez, de Celis Ferrari, Anezka C R, Pfiffer, Tulio Eduardo, Alex, Alexandra Kichfy, Nebuloni, Daniela, Carneiro, Allyne S, Caparelli, Fernanda, Senna, Luiz, Lobo, Juliana, Hoff, Paulo Marcelo, Riechelmann, Rachel P
Format: Artigo
Sprog:Inglês
Udgivet: Cancer Intelligence 2015
Fag:
Clinical Study
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4544571/
https://ncbi.nlm.nih.gov/pubmed/26316884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2015.563
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker